Sanofi sells its Andheri building in Mumbai for Rs 111 cr

Sanofi India shares on Friday closed 0.61 percent down at Rs 4,455.85 per scrip on BSE.

Cholesterol drug wins green light from US panel of experts

A US advisory panel urged regulators Tuesday to approve a new cholesterol drug that promises to reduce death from cardiovascular disease.

CCI imposes Rs 64 crore fine on GlaxoSmithKline, Sanofi

Every year, the government invites tenders for purchase of meningitis vaccine that is required to be administered upon Haj pilgrims.

Shantha Biotechnics delivers 4 lakh doses of Shan5

Sanofi Pasteur, the vaccines division of Sanofi, announced today that its affiliate Shantha Biotechnics has delivered the first 400,000 doses of the paediatric Pentavalent vaccine, Shan5 to support the immunisation of children in Gwalior and Jabalpur in Madhya Pradesh.

Sanofi picks 20% stake in Apollo Sugar Clinics for Rs 90 crore

French healthcare major Sanofi is picking up 20 percent stake for Rs 90 crore in Apollo Sugar Clinics, a diabetes care chain of Chennai-based healthcare major Apollo Hospitals.

Sanofi sacks CEO over management row, shares plunge

French drugmaker Sanofi fired its chief executive on Wednesday after a row over his management style, sending the pharmaceutical giant`s shares sharply lower.

'Sugar clinics' for improved diabetes care

  To curb the rise of diabetes in India, a city hospital here Tuesday announced it would set up 50 "sugar clinics" for easy access to integrated diabetes care while promoting early detection.

Sanofi inks marketing pact with Emcure for cancer drugs

Drug firm Sanofi has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India.

Sanofi shows profit surge, shares jump

French pharmaceutical giant Sanofi achieved a profits leap in the second quarter of the year and raised its forecast for the year, in a results statement on Thursday which boosted shares.

Sanofi faces US class action over MS drug Lemtrada

A US law firm is launching a class action against France`s Sanofi over what it calls misleading statements on the safety and efficacy of its multiple sclerosis drug Lemtrada.

New data backs promise of long-acting Sanofi insulin

An improved version of Sanofi`s diabetes drug Lantus is better than the old one at controlling blood sugar levels and comes with fewer hypoglycemic events, new late-stage trial data showed on Tuesday.

Sanofi launches new antimalarial drug

The pharmaceutical company Sanofi has launched the large-scale production of a partially synthetic version of artemisinin.

Sanofi India to double consumer healthcare biz to Rs 1,000 cr

Sanofi India (previously known as Aventis Pharma) Tuesday said it aims to double its consumer healthcare business in the next five years.

LIC trims stake in Tata Global Beverages to 7.63%

LIC sold over 1.28 crore shares, representing around 2.08 percent stake, in the Tata group firm. These scrips were offloaded between August 23 and December 26, 2012, through open market sale, Tata Global Beverages said in a filing to the BSE.

Sanofi India net down 6.38% at Rs 51.3 cr in Jul-Sept

The company had posted a net profit of Rs 54.8 crore for the same quarter last fiscal.

Sanofi launches re-usable insulin pen

Sanofi India Ltd today announced the launch of AllStar, its first indigenously manufactured reusable insulin pen.

Soon, vaccine to prevent dengue infection

French pharmaceutical company Sanofi is conducting a key trial to prevent an estimated 100 million cases of dengue infection each year.

Soon, vaccine to prevent dengue infection

French pharmaceutical company Sanofi is conducting a key trial to prevent an estimated 100 million cases of dengue infection each year.

Sanofi to test Parkinson`s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson`s disease.